Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38367671)

  • 1. Extracellular domain mutations of the EGF receptor differentially modulate high-affinity and low-affinity responses to EGF receptor ligands.
    Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2024 Mar; 300(3):105763. PubMed ID: 38367671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palmitoylation of the EGF receptor impairs signal transduction and abolishes high-affinity ligand binding.
    Macdonald-Obermann JL; Pike LJ
    Biochemistry; 2009 Mar; 48(11):2505-13. PubMed ID: 19196031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptors containing a single tyrosine in their C-terminal tail bind different effector molecules and are signaling-competent.
    Gill K; Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2017 Dec; 292(50):20744-20755. PubMed ID: 29074618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of substitution of threonine 654 of the epidermal growth factor receptor on epidermal growth factor-mediated activation of phospholipase C.
    Decker SJ; Ellis C; Pawson T; Velu T
    J Biol Chem; 1990 Apr; 265(12):7009-15. PubMed ID: 2108964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF.
    Saito T; Okada S; Ohshima K; Yamada E; Sato M; Uehara Y; Shimizu H; Pessin JE; Mori M
    Endocrinology; 2004 Sep; 145(9):4232-43. PubMed ID: 15192046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioblastoma mutations alter EGFR dimer structure to prevent ligand bias.
    Hu C; Leche CA; Kiyatkin A; Yu Z; Stayrook SE; Ferguson KM; Lemmon MA
    Nature; 2022 Feb; 602(7897):518-522. PubMed ID: 35140400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of threonine residues in regulation of the epidermal growth factor receptor by protein kinase C and mitogen-activated protein kinase.
    Morrison P; Takishima K; Rosner MR
    J Biol Chem; 1993 Jul; 268(21):15536-43. PubMed ID: 8393447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenesis reveals a role for epidermal growth factor receptor extracellular subdomain IV in ligand binding.
    Saxon ML; Lee DC
    J Biol Chem; 1999 Oct; 274(40):28356-62. PubMed ID: 10497195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CR1/CR2 interactions modulate the functions of the cell surface epidermal growth factor receptor.
    Walker F; Orchard SG; Jorissen RN; Hall NE; Zhang HH; Hoyne PA; Adams TE; Johns TG; Ward C; Garrett TP; Zhu HJ; Nerrie M; Scott AM; Nice EC; Burgess AW
    J Biol Chem; 2004 May; 279(21):22387-98. PubMed ID: 15016810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.
    Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R
    Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancer.
    Nair S; Trummell HQ; Rajbhandari R; Thudi NK; Nozell SE; Warram JM; Willey CD; Yang ES; Placzek WJ; Bonner JA; Bredel M
    PLoS One; 2020; 15(2):e0229077. PubMed ID: 32069320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical characterization of mutant EGF receptors expressed in the hemopoietic cell line BaF/3.
    Walker F; Hibbs ML; Zhang HH; Gonez LJ; Burgess AW
    Growth Factors; 1998; 16(1):53-67. PubMed ID: 9777370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and biochemical activities of a chimeric epidermal growth factor-Elk receptor tyrosine kinase.
    Lhoták V; Pawson T
    Mol Cell Biol; 1993 Nov; 13(11):7071-9. PubMed ID: 8413296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmembrane signaling by epidermal growth factor receptors lacking autophosphorylation sites.
    Decker SJ
    J Biol Chem; 1993 May; 268(13):9176-9. PubMed ID: 8387484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor.
    Swindle CS; Tran KT; Johnson TD; Banerjee P; Mayes AM; Griffith L; Wells A
    J Cell Biol; 2001 Jul; 154(2):459-68. PubMed ID: 11470832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The membrane-proximal intracellular domain of the epidermal growth factor receptor underlies negative cooperativity in ligand binding.
    Adak S; Yang KS; Macdonald-Obermann J; Pike LJ
    J Biol Chem; 2011 Dec; 286(52):45146-55. PubMed ID: 22069315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor cytoplasmic domain mutations trigger ligand-independent transformation.
    Massoglia S; Gray A; Dull TJ; Munemitsu S; Kun HJ; Schlessinger J; Ullrich A
    Mol Cell Biol; 1990 Jun; 10(6):3048-55. PubMed ID: 1971419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational removal of the Thr669 and Ser671 phosphorylation sites alters substrate specificity and ligand-induced internalization of the epidermal growth factor receptor.
    Heisermann GJ; Wiley HS; Walsh BJ; Ingraham HA; Fiol CJ; Gill GN
    J Biol Chem; 1990 Aug; 265(22):12820-7. PubMed ID: 2115882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herstatin, an autoinhibitor of the human epidermal growth factor receptor 2 tyrosine kinase, modulates epidermal growth factor signaling pathways resulting in growth arrest.
    Justman QA; Clinton GM
    J Biol Chem; 2002 Jun; 277(23):20618-24. PubMed ID: 11934884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of phospholipase A2 activity by epidermal growth factor (EGF) in CHO cells transfected with human EGF receptor. Role of receptor cytoplasmic subdomain.
    Clark S; Dunlop M
    Biochem J; 1991 Mar; 274 ( Pt 3)(Pt 3):715-21. PubMed ID: 1826422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.